کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2012956 1541861 2014 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism
ترجمه فارسی عنوان
تأثیرات ژنتیکی بر پاسخ به الکل و پاسخ به داروها برای الکل
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
چکیده انگلیسی


• Genetic variants producing the alcohol flushing syndrome protect against alcoholism.
• Low level of response to alcohol increases risk for alcoholism.
• The functional OPRM1 A118G polymorphism predicts response to alcohol and naltrexone.
• The functional SLC6A4 polymorphisms predict response to SSRIs and ondansetron.

Although very many individuals drink alcohol at safe levels, a significant proportion escalates their consumption with addiction as the end result. Alcoholism is a common, moderately heritable, psychiatric disorder that is accompanied by considerable morbidity and mortality. Variation in clinical presentation suggests inter-individual variation in mechanisms of vulnerability including genetic risk factors. The development of addiction is likely to involve numerous functional genetic variants of small effects. The first part of this review will focus on genetic factors underlying inter-individual variability in response to alcohol consumption, including variants in alcohol metabolizing genes that produce an aversive response (the flushing syndrome) and variants that predict the level of subjective and physiological response to alcohol. The second part of this review will report on genetic variants that identify subgroups of alcoholics who are more likely to respond to pharmacotherapy to reduce levels of drinking or maintain abstinence.Genetic analyses of the level of response to alcohol, particularly of the functional OPRM1 A118G polymorphism and 5′ and 3′ functional polymorphisms in SLC6A4, are beginning to provide insights into the etiology of alcoholism and also genotype-stratified subgroup responses to naltrexone and SSRIs/ondansetron respectively. Because of large inter-ethnic variation in allele frequencies, the relevance of these functional polymorphisms will vary between ethnic groups. However there are relatively few published studies in this field, particularly with large sample sizes in pharmacogenetic studies, therefore it is premature to draw any conclusions at this stage.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pharmacology Biochemistry and Behavior - Volume 123, August 2014, Pages 17–24
نویسندگان
,